Ray Dingledine
Affiliations: | Emory University, Atlanta, GA |
Area:
epilepsy, glutamate receptorsWebsite:
https://med.emory.edu/departments/pharmacology-chemical-biology/people/profile/?u=RDINGLEGoogle:
"Ray Dingledine"Bio:
http://www.pharm.emory.edu/dingledine/people/index.html
https://med.emory.edu/departments/pharmacology-chemical-biology/about-us/dept-chair-history.html
https://searchworks.stanford.edu/view/12308466
Mean distance: 12.15 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Avram Goldstein | grad student | 1971-1975 | Stanford University Medical School | |
| (Single neuron studies of narcotic action in the guinea pig myenteric plexus.) | ||||
| Leslie Iversen | post-doc | 1975-1977 | Cambridge | |
| John S. Kelly | post-doc | 1975-1977 | University of Cambridge and MRC | |
| Per Andersen | post-doc | 1977-1978 | University of Oslo, Norway | |
| Steve F. Heinemann | research scientist | 1990-1991 | Salk Institute | |
Children
Sign in to add traineeCollaborators
Sign in to add collaborator| James O. McNamara | collaborator | 1978- | Duke University Department of Neurobiology | |
| Avtar Roopra | collaborator | 2001- | UW Madison | |
| Olga Taraschenko | collaborator | 2016- | Emory School of Medicine | |
| Nigel P. Pedersen | collaborator | 2019- | Emory School of Medicine | |
| Steve F. Heinemann | collaborator | 1990-1991 | Emory | |
| (sabbatical) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alemán-Ruiz C, Wang W, Dingledine R, et al. (2023) Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticus. Scientific Reports. 13: 5651 |
| Harris LD, Regan MC, Myers SJ, et al. (2023) Novel GluN2B-Selective NMDA Receptor Negative Allosteric Modulator Possesses Intrinsic Analgesic Properties and Enhances Analgesia of Morphine in a Rodent Tail Flick Pain Model. Acs Chemical Neuroscience |
| Zaczek R, Traynelis SF, Dingledine R, et al. (2023) Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor Inhibitor. Clinical Pharmacology in Drug Development |
| Jiang C, Caskurlu A, Ganesh T, et al. (2020) Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation. Brain, Behavior, & Immunity - Health. 8: 100132 |
| Jiang C, Amaradhi R, Ganesh T, et al. (2020) An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 Receptors. Acs Chemical Neuroscience |
| Rojas A, Wang J, Glover A, et al. (2020) Urethane attenuates early neuropathology of diisopropylfluorophosphate-induced status epilepticus in rats. Neurobiology of Disease. 104863 |
| Amaradhi R, Banik A, Mohammed S, et al. (2020) Potent, selective, water soluble, brain-permeable EP2 receptor antagonist for use in central nervous system disease models. Journal of Medicinal Chemistry |
| Jiang C, Amaradhi R, Ganesh T, et al. (2020) A Noncompetitive and Selective Prostaglandin EP2 Antagonist with Anti‐inflammatory Property The Faseb Journal. 34: 1-1 |
| Khan N, Schoenike B, Basu T, et al. (2019) A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy. Plos One. 14: e0226733 |
| Rojas A, Banik A, Chen D, et al. (2019) A novel microglia cell line expressing the human EP2 receptor. Acs Chemical Neuroscience |